Literature DB >> 17350686

MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: an association and meta-analysis.

Behrooz Z Alizadeh1, Peter Eerligh, Arno R van der Slik, Arun Shastry, Alexandra Zhernakova, Gustavo Valdigem, Jan G Bruining, Carani B Sanjeevi, Cisca Wijmenga, Bart O Roep, Bobby P C Koeleman.   

Abstract

The association of the HLA complex on chromosome 6 does not explain total linkage of the HLA region to Type 1 Diabetes (T1D), leading to the hypothesis that there may be additional causal genes in the HLA region for immune-related disorders. Reports on the MHC Class I chain-related A (MICA) gene as candidate for association with T1D are contradicting. We investigated whether variation in MICA is associated to T1D in a cohort of 350 unrelated individuals with juvenile-onset T1D and 540 control subjects, followed by a meta-analysis of 14 studies. We also investigated an HLA-independent association for MICA with T1D. In our case-control study, we found that the MICA*A5 variant was significantly associated with an increased risk for T1D, while MICA*A6 was significantly associated with a decreased risk that was confirmed by our meta-analysis. However, the meta-analysis did not show an association of MICA*A5 T1D. Analysis of MICA alleles conditional on T1D-associated high-risk MHC class II haplotypes revealed that MICA*A6 was associated with an increased risk for T1D when this marker co-occurred with HLA DQ2DR17 T1D-risk-haplotypes. In contrast, MICA*A6 reduced the risk from the HLA DQ8DR4 T1D-risk haplotype. Moreover, MICA*A9 showed a significant association to increased risk for T1D on DQ8DR4 haplotypes. Co-inheritance of MICA*A6 with the HLA DQ2DR17 haplotype in T1D indicates this haplotype may carry the additional genetic factors for T1D, but our study does not support an independent association between MICA variants and T1D.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350686     DOI: 10.1016/j.molimm.2007.01.032

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Association of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population.

Authors:  Rachida Raache; Khadidja Belanteur; Habiba Amroun; Amel Benyahia; Amel Heniche; Malha Azzouz; Safia Mimouni; Thibaud Gervais; Dominique Latinne; Aissa Boudiba; Nabila Attal; Mohamed Cherif Abbadi
Journal:  Clin Vaccine Immunol       Date:  2012-02-08

Review 2.  Adrenal insufficiency: etiology, diagnosis and treatment.

Authors:  Nicola Neary; Lynnette Nieman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

3.  Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1.

Authors:  A M Valdes; G Thomson
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

4.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

5.  Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.

Authors:  Taylor M Triolo; Erin E Baschal; Taylor K Armstrong; Carrie S Toews; Pamela R Fain; Marian J Rewers; Liping Yu; Dongmei Miao; George S Eisenbarth; Peter A Gottlieb; Jennifer M Barker
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

6.  Identifying the lungs as a susceptible site for allele-specific regulatory changes associated with type 1 diabetes risk.

Authors:  Daniel Ho; Denis M Nyaga; William Schierding; Richard Saffery; Jo K Perry; John A Taylor; Mark H Vickers; Andreas W Kempa-Liehr; Justin M O'Sullivan
Journal:  Commun Biol       Date:  2021-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.